BSE filing, NSE: SHRIDINESH. Summary written from the filing by ALFA Finder's alert engine.
Shri Dinesh Mills Ltd: key numbers
- Share price
- ₹384.00
- Market cap
- ₹215.1 Cr
- Revenue (annual)
- ₹67.72 Cr
- Net profit (annual)
- ₹7.60 Cr
- P/E (TTM)
- 17.7×Sector 34.2×
- Promoter holding
- 49.79%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shri Dinesh Mills Ltd
All →Shri Dinesh Mills Promoter Selling (Off-Market)
Promoter Arushaben Patel gifted all 7,68,852 Shri Dinesh Mills shares to promoter Nimish Patel in an inter-se transfer. No cash consideration was involved.
Shri Dinesh Mills Promoter Buying (Off-Market)
Nimish Upendrabhai Patel received 13,56,427 shares (24.22%) of Shri Dinesh Mills via inter-se gift from immediate relatives. No consideration was involved and total promoter group holding remained unchanged.
- Promoter stake change
- +24.22%
Shri Dinesh Mills Q2 FY27 Results: Net Profit ₹3 Cr, Up 57.9% YoY
Shri Dinesh Mills Ltd reported revenue from operations of ₹22.4 Cr (+29.5% YoY) and net profit of ₹3 Cr (+57.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹3 Cr · +57.9% YoY
Shri Dinesh Mills Promoter Buying (Off-Market)
Bharatbhai Upendrabhai Patel will receive 13,63,245 shares (24.34%) of Shri Dinesh Mills via inter-se gift from promoter-group relatives. No consideration is involved; total promoter holding remains unchanged.
- Promoter stake change
- +24.34%
Shri Dinesh Mills Annual General Meeting
Shri Dinesh Mills Ltd. announced results of the postal ballot. Shareholders approved the alteration and adoption of the Memorandum of Association.
Shri Dinesh Mills Board Meeting Date
Shri Dinesh Mills Ltd has scheduled a Board meeting for October 26, 2026, to consider its unaudited financial results for the quarter and half-year.
Other merger & restructuring announcements
All →Fermenta Biotech Merger & Restructuring
Fermenta Biotech Limited's board has approved the closure of its inactive wholly-owned subsidiary, Fermenta Biotech (UK) Limited. The move aims to reorganize corporate structure and reduce compliance costs following the UK's exit from the EU.
Thomas Cook (India) Merger & Restructuring
Thomas Cook (India) Ltd announced that the NCLT Mumbai Bench has issued directions regarding its composite scheme of arrangement. The scheme involves demergers and amalgamations with Sterling Holiday Resorts and other group entities.
Narayana Hrudayalaya Merger & Restructuring
Narayana Hrudayalaya's NCLT Bengaluru bench sanctioned the demerger of clinical services from its subsidiary NH Integrated Care. Order uploaded today; effectiveness awaits certified copy filings.
Abans Enterprises Merger & Restructuring
Abans Enterprises' board approved voluntary liquidation of wholly owned subsidiary AGJT, subject to shareholder approval. Completion is expected within one year.
- Execution
- Expected within one year, subject to approvals and statutory formalities
Max Estates Merger & Restructuring Worth ₹0.01 Cr
Max Estates will subscribe to 10,000 shares worth ₹1 lakh in a yet-to-be-incorporated real estate company. The entity awaits Ministry of Corporate Affairs approval.
- Value
- ₹0.01 Cr
Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days